Digital Technology’s role in supplying healthcare professionals with... Insight on what HCPs need from the pharmaceutical industry to improve access to reliable, trusted medicines information.
Digital Balancing innovation and implementation: Embracing agentic A... A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.
Digital Tech for good: AI agents critical to improving NHS services How NHS Trusts are harnessing the latest AI solutions to optimise the experience for their employees and care on behalf of patients.
Digital Unicorns, AI, and the future of health: Highlights from HLTH... Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.
Digital Why security-first design is the fix to stalling AI pilot to... For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
Digital Asking the right questions around AI, with Brian Alexander, ... At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
